MinorPlant alkaloid (isoquinoline), food supplement×Vitamins. Haemopoietic stimulants
Updated · Methodology
Mechanism
Folic acid is absorbed in the duodenum and jejunum, converted in the liver to 5-methyltetrahydrofolate and excreted in faeces and urine (Acfol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 5.2). According to the folic acid SmPC, zinc supplements, antacids, colestyramine, colestipol, antiepileptics, oral contraceptives, methotrexate, several other drugs and alcohol impair folate absorption or metabolism (Acfol SmPC, AEMPS, section 4.5). Berberine is a plant alkaloid. It is not authorised as a medicine in Spain and is sold as a food supplement, usually at 250–500 mg two or three times a day (LiverTox, NIH). In healthy men, berberine 300 mg three times a day for two weeks inhibited CYP2D6, CYP2C9 and CYP3A4: exposure to midazolam, a CYP3A4 substrate, rose by 40% (Guo et al., 2012). This combination has not been studied, and no interaction mechanism is known. Berberine is not on the folic acid SmPC list, and the SmPC does not name the enzymes berberine inhibits as part of folate metabolism (Acfol SmPC, AEMPS, sections 4.5 and 5.2).
Symptoms
No symptoms caused by this combination have been described. Prolonged high doses of folic acid can lower blood vitamin B12 concentrations (Acfol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.4). Berberine's adverse effects are usually mild and transient: nausea, bloating, diarrhoea or constipation. In controlled trials they were no more frequent than with placebo, and no liver injury from berberine has been described (LiverTox, NIH).
Management
The combination can be used and no dose change is needed. There are no data on an interaction, and no mechanism that would cause one is known (Acfol SmPC, Spanish Agency of Medicines and Medical Devices, AEMPS, section 4.5). With long-term high doses of folic acid, bear in mind that it can lower blood vitamin B12 levels (Acfol SmPC, AEMPS, section 4.4). Because berberine inhibits CYP2D6, CYP2C9 and CYP3A4, bear in mind that it may raise the levels of other drugs metabolised by these enzymes (Guo et al., 2012).
Your whole list in one report
Up to 15 drugs: every pair in one table and a PDF report. Your first report is free: we only ask for your email
Add more drugsMedicine list: everything you take in one place →
Sources
- European journal of clinical pharmacology: Repeated administration of berberine inhibits cytochromes P450 in humans. (2012)– Repeated administration of berberine inhibits cytochromes P450 in humans.. European journal of clinical pharmacology 2012. PMID 21870106.
- AEMPS: Ficha técnica: Ácido fólico, Acfol 5 mg comprimidos (nº registro 11265), sección 4.5 (2022)– AEMPS, CIMA, nº registro 11265 (Acfol 5 mg comprimidos, Italfarmaco), revisión 11/2022, secciones 4.1, 4.3, 4.4, 4.5 y 5.2
- LiverTox NIDDK: Berberine – LiverTox (2020)– LiverTox: Clinical and Research Information on Drug-Induced Liver Injury, NIDDK, Berberine, last update 06.10.2020